American Heart Association
Next-Gen Therapies, Real-World Impact: Advancing Cardiovascular Outcomes Through Innovation and Insight
Moderated Digital Poster Session
Population Science Zone, Moderated Digital Poster 12
Nov 8th , 01:45 PM - 02:55 PM
01 : 45 PM
Clinical Effects of Acoramidis Versus Placebo in the ATTRibute-CM Study: Observations from the Intention-to-Treat Population
Morbach Caroline, Pfister Roman, Dintsios Charalabos Markos, Plate Henrike Charlotte, Thate-waschke Inga-marion, Herrmann Stefan, Zeitler Stefan, Yilmaz Ali, Störk Stefan
Final Pr. ID: MP491
Authors: Morbach Caroline, Pfister Roman, Dintsios Charalabos Markos, Plate Henrike Charlotte, Thate-waschke Inga-marion, Herrmann Stefan, Zeitler Stefan, Yilmaz Ali, Störk Stefan
Keywords: Amyloidosis , Cardiomyopathy , Clinical trials
01 : 52 PM
Cumulative exposure to low-density lipoprotein cholesterol levels explains the cardiovascular benefit over time in randomized clinical trials
Galimberti Federica, Olmastroni Elena, Casula Manuela, Catapano Alberico
Final Pr. ID: MP492
Authors: Galimberti Federica, Olmastroni Elena, Casula Manuela, Catapano Alberico
Keywords: Statins , Cardiovascular Risk , LDL , Atherosclerosis , Cardiovascular disease prevention
01 : 59 PM
EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics
Bonaca Marc, Wang Huei, Wu You, Cyrille Marcoli, Cannon Christopher, Hess Connie, Tavares Caio, James Stefan, Oldgren Jonas, Bhatt Deepak, Abbott Jinnette, Mehran Roxana, Berwanger Otavio
Final Pr. ID: MP493
Authors: Bonaca Marc, Wang Huei, Wu You, Cyrille Marcoli, Cannon Christopher, Hess Connie, Tavares Caio, James Stefan, Oldgren Jonas, Bhatt Deepak, Abbott Jinnette, Mehran Roxana, Berwanger Otavio
Keywords: Myocardial infarction , Atherosclerosis , LDL , PCSK9
02 : 06 PM
Disparities in Major Adverse Cardiovascular Outcomes Based on Body Mass Index and Estimated Glomerular Filtration Rate in Glucagon-like Peptide-1 Receptor Agonists Users Among Patients With and Without Diabetes Mellitus: A Meta-analysis of 9 Randomized Controlled trials.
Jaiswal Vikash, Jaiswal Akash
Final Pr. ID: MP494
Authors: Jaiswal Vikash, Jaiswal Akash
Keywords: Obesity , Chronic Kidney Disease , Diabetes Mellitus , Outcomes , Prevention
02 : 13 PM
Laroprovstat (AZD0780) an oral, small molecule PCSK9 inhibitor demonstrates improvements in the lipid profile in participants with hypercholesterolemia: Results from a Phase 1 study
Vega Rick, Yu Hongtao, Barbour April, Miliotis Tasso, Ryaboshapkina Maria, Andersson Marielle, Carter Debra, Bergh Niklas, Rosenmeier Jaya
Final Pr. ID: MP496
Authors: Vega Rick, Yu Hongtao, Barbour April, Miliotis Tasso, Ryaboshapkina Maria, Andersson Marielle, Carter Debra, Bergh Niklas, Rosenmeier Jaya
Keywords: PCSK9 , Dyslipidemia , Hypercholesterolemia , Clinical trials
02 : 20 PM
Adverse Events Associated with Early vs. Late SGLT2i Initiation After Heart Failure Hospitalization: A Target Trial Emulation Study
Moon Jungyeon, Naimark David, Stukel Therese, Tu Karen, Ko Dennis, Jackevicius Cynthia, Godoy Lucas, Austin Peter, Chong Alice, Fang Jiming, Odutayo Ayodele, Udell Jacob, Atzema Clare, Booth Gillian
Final Pr. ID: MP497
Authors: Moon Jungyeon, Naimark David, Stukel Therese, Tu Karen, Ko Dennis, Jackevicius Cynthia, Godoy Lucas, Austin Peter, Chong Alice, Fang Jiming, Odutayo Ayodele, Udell Jacob, Atzema Clare, Booth Gillian
Keywords: Heart failure , Outcomes , Drugs , Kidney Disease
02 : 27 PM
Cardiovascular Outcomes of Oral Incretin-Based Therapies in Type 2 Diabetes: A Systematic Review and Meta-Analysis of 62,821 Patients
Ali Muhammad Faizan, Tariq Ammarah, Arshad Muhammad Usman, Binashikhbubkr Noof K., Alam Umama, Eltawansy Sherif, Abdul Malik Mohammad Hamza Bin, Iqbal Asad, Hemida Mohamed Fawzi, Ahmed Ashraf, Naseer Faisal, Shazly Omar, Ahmad Husnain, Shafi Nimra, Mohammed Omer Farooq
Final Pr. ID: MP498
Authors: Ali Muhammad Faizan, Tariq Ammarah, Arshad Muhammad Usman, Binashikhbubkr Noof K., Alam Umama, Eltawansy Sherif, Abdul Malik Mohammad Hamza Bin, Iqbal Asad, Hemida Mohamed Fawzi, Ahmed Ashraf, Naseer Faisal, Shazly Omar, Ahmad Husnain, Shafi Nimra, Mohammed Omer Farooq
Keywords: Cardiovascular health , Cardiovascular Risk , Cardiovascular disease prevention , Outcomes , Diabetes (Type II)
02 : 34 PM
Meta-Analysis on Acute Pericarditis Treatment: Colchicine Alone vs. Colchicine + NSAIDs (Aspirin or Ibuprofen)
Singh Chanpreet, Alsabbagh Mourad, Augustine George
Final Pr. ID: MP499
Authors: Singh Chanpreet, Alsabbagh Mourad, Augustine George
Keywords: Pericarditis , Antiplatelet drugs , Aspirin
02 : 41 PM
The association between GLP-1 RA initiation and cardiovascular events among patients treated with direct oral anticoagulants: A target trial emulation
Du Fanxing, Singh Ospina Naykky, Cicali Brian, Ruzieh Mohammed, Jiao Tianze
Final Pr. ID: MP500
Authors: Du Fanxing, Singh Ospina Naykky, Cicali Brian, Ruzieh Mohammed, Jiao Tianze
Keywords: Cardiovascular Risk , Diabetes (Type II) , Anticoagulants , Drug interactions , Stroke
02 : 20 PM
Adverse Events Associated with Early vs. Late SGLT2i Initiation After Heart Failure Hospitalization: A Target Trial Emulation Study
Moon Jungyeon, Naimark David, Stukel Therese, Tu Karen, Ko Dennis, Jackevicius Cynthia, Godoy Lucas, Austin Peter, Chong Alice, Fang Jiming, Odutayo Ayodele, Udell Jacob, Atzema Clare, Booth Gillian
Final Pr. ID: MP497
Authors: Moon Jungyeon, Naimark David, Stukel Therese, Tu Karen, Ko Dennis, Jackevicius Cynthia, Godoy Lucas, Austin Peter, Chong Alice, Fang Jiming, Odutayo Ayodele, Udell Jacob, Atzema Clare, Booth Gillian
Keywords: Heart failure , Outcomes , Drugs , Kidney Disease
02 : 27 PM
Cardiovascular Outcomes of Oral Incretin-Based Therapies in Type 2 Diabetes: A Systematic Review and Meta-Analysis of 62,821 Patients
Ali Muhammad Faizan, Tariq Ammarah, Arshad Muhammad Usman, Binashikhbubkr Noof K., Alam Umama, Eltawansy Sherif, Abdul Malik Mohammad Hamza Bin, Iqbal Asad, Hemida Mohamed Fawzi, Ahmed Ashraf, Naseer Faisal, Shazly Omar, Ahmad Husnain, Shafi Nimra, Mohammed Omer Farooq
Final Pr. ID: MP498
Authors: Ali Muhammad Faizan, Tariq Ammarah, Arshad Muhammad Usman, Binashikhbubkr Noof K., Alam Umama, Eltawansy Sherif, Abdul Malik Mohammad Hamza Bin, Iqbal Asad, Hemida Mohamed Fawzi, Ahmed Ashraf, Naseer Faisal, Shazly Omar, Ahmad Husnain, Shafi Nimra, Mohammed Omer Farooq
Keywords: Cardiovascular health , Cardiovascular Risk , Cardiovascular disease prevention , Outcomes , Diabetes (Type II)
01 : 45 PM
Clinical Effects of Acoramidis Versus Placebo in the ATTRibute-CM Study: Observations from the Intention-to-Treat Population
Morbach Caroline, Pfister Roman, Dintsios Charalabos Markos, Plate Henrike Charlotte, Thate-waschke Inga-marion, Herrmann Stefan, Zeitler Stefan, Yilmaz Ali, Störk Stefan
Final Pr. ID: MP491
Authors: Morbach Caroline, Pfister Roman, Dintsios Charalabos Markos, Plate Henrike Charlotte, Thate-waschke Inga-marion, Herrmann Stefan, Zeitler Stefan, Yilmaz Ali, Störk Stefan
Keywords: Amyloidosis , Cardiomyopathy , Clinical trials
01 : 52 PM
Cumulative exposure to low-density lipoprotein cholesterol levels explains the cardiovascular benefit over time in randomized clinical trials
Galimberti Federica, Olmastroni Elena, Casula Manuela, Catapano Alberico
Final Pr. ID: MP492
Authors: Galimberti Federica, Olmastroni Elena, Casula Manuela, Catapano Alberico
Keywords: Statins , Cardiovascular Risk , LDL , Atherosclerosis , Cardiovascular disease prevention
02 : 06 PM
Disparities in Major Adverse Cardiovascular Outcomes Based on Body Mass Index and Estimated Glomerular Filtration Rate in Glucagon-like Peptide-1 Receptor Agonists Users Among Patients With and Without Diabetes Mellitus: A Meta-analysis of 9 Randomized Controlled trials.
Jaiswal Vikash, Jaiswal Akash
Final Pr. ID: MP494
Authors: Jaiswal Vikash, Jaiswal Akash
Keywords: Obesity , Chronic Kidney Disease , Diabetes Mellitus , Outcomes , Prevention
01 : 59 PM
EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics
Bonaca Marc, Wang Huei, Wu You, Cyrille Marcoli, Cannon Christopher, Hess Connie, Tavares Caio, James Stefan, Oldgren Jonas, Bhatt Deepak, Abbott Jinnette, Mehran Roxana, Berwanger Otavio
Final Pr. ID: MP493
Authors: Bonaca Marc, Wang Huei, Wu You, Cyrille Marcoli, Cannon Christopher, Hess Connie, Tavares Caio, James Stefan, Oldgren Jonas, Bhatt Deepak, Abbott Jinnette, Mehran Roxana, Berwanger Otavio
Keywords: Myocardial infarction , Atherosclerosis , LDL , PCSK9
02 : 13 PM
Laroprovstat (AZD0780) an oral, small molecule PCSK9 inhibitor demonstrates improvements in the lipid profile in participants with hypercholesterolemia: Results from a Phase 1 study
Vega Rick, Yu Hongtao, Barbour April, Miliotis Tasso, Ryaboshapkina Maria, Andersson Marielle, Carter Debra, Bergh Niklas, Rosenmeier Jaya
Final Pr. ID: MP496
Authors: Vega Rick, Yu Hongtao, Barbour April, Miliotis Tasso, Ryaboshapkina Maria, Andersson Marielle, Carter Debra, Bergh Niklas, Rosenmeier Jaya
Keywords: PCSK9 , Dyslipidemia , Hypercholesterolemia , Clinical trials
02 : 34 PM
Meta-Analysis on Acute Pericarditis Treatment: Colchicine Alone vs. Colchicine + NSAIDs (Aspirin or Ibuprofen)
Singh Chanpreet, Alsabbagh Mourad, Augustine George
Final Pr. ID: MP499
Authors: Singh Chanpreet, Alsabbagh Mourad, Augustine George
Keywords: Pericarditis , Antiplatelet drugs , Aspirin
02 : 41 PM
The association between GLP-1 RA initiation and cardiovascular events among patients treated with direct oral anticoagulants: A target trial emulation
Du Fanxing, Singh Ospina Naykky, Cicali Brian, Ruzieh Mohammed, Jiao Tianze
Final Pr. ID: MP500
Authors: Du Fanxing, Singh Ospina Naykky, Cicali Brian, Ruzieh Mohammed, Jiao Tianze
Keywords: Cardiovascular Risk , Diabetes (Type II) , Anticoagulants , Drug interactions , Stroke